Evidence map›Paper›PMID 34032265›Full record

ArticleThe Biochemical journal2021

Kinetics of the multitasking high-affinity Win binding site of WDR5 in restricted and unrestricted conditions.

Ali Imran, Brandon S Moyer, Ashley J Canning, Dan Kalina, Thomas M Duncan, Kelsey J Moody, Aaron J Wolfe, Michael S Cosgrove, Liviu Movileanu

Open access · hybridAbstract read
In one paragraph

Article in The Biochemical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Interplay of Affinity and Surface Tethering in Protein Recognition.The journal of physical chemistry letters · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Ali ImranDepartment of Physics, Syracuse University, 201 Physics Building, Syracuse, New York 13244-1130, U.S.A.
Brandon S MoyerIchor Therapeutics, Inc., 2521 US Route 11, LaFayette, New York 13084, U.S.A.
Ashley J CanningDepartment of Biochemistry and Molecular Biology, State University of New York, Upstate Medical University, 4249 Weiskotten Hall, 766 Irving Avenue, Syracuse, New York 13210, U.S.A.
Dan KalinaIchor Therapeutics, Inc., 2521 US Route 11, LaFayette, New York 13084, U.S.A.
Thomas M DuncanDepartment of Biochemistry and Molecular Biology, State University of New York, Upstate Medical University, 4249 Weiskotten Hall, 766 Irving Avenue, Syracuse, New York 13210, U.S.A.
Kelsey J MoodyDepartment of Physics, Syracuse University, 201 Physics Building, Syracuse, New York 13244-1130, U.S.A.
Aaron J WolfeDepartment of Physics, Syracuse University, 201 Physics Building, Syracuse, New York 13244-1130, U.S.A.
Michael S CosgroveDepartment of Biochemistry and Molecular Biology, State University of New York, Upstate Medical University, 4249 Weiskotten Hall, 766 Irving Avenue, Syracuse, New York 13210, U.S.A.
Liviu MovileanuDepartment of Physics, Syracuse University, 201 Physics Building, Syracuse, New York 13244-1130, U.S.A.ORCID 0000-0002-2525-3341
SUNY College of Environmental Science and Forestry · USSUNY Upstate Medical University · USCarnegie Hall · USIo Therapeutics (United States) · USSyracuse University · US

Funding

Molecular Mechanisms for the Assembly and Regulation of the MLL1 Core ComplexR01CA140522 · NCI · UPSTATE MEDICAL UNIVERSITY · PI COSGROVE, MICHAEL S. · 2010 to 2019
$3.6M
Disentanglement of the MLL-WDR5 Protein-Protein Recognition EventsR01GM129429 · NIGMS · SYRACUSE UNIVERSITY · PI MOVILEANU, LIVIU · 2018 to 2021
$1.3M
NCI NIH HHS R01 CA140522NIGMS NIH HHS R01 GM129429
6 · The paper itself

Abstract

Recent advances in quantitative proteomics show that WD40 proteins play a pivotal role in numerous cellular networks. Yet, they have been fairly unexplored and their physical associations with other proteins are ambiguous. A quantitative understanding of these interactions has wide-ranging significance. WD40 repeat protein 5 (WDR5) interacts with all members of human SET1/MLL methyltransferases, which regulate methylation of the histone 3 lysine 4 (H3K4). Here, using real-time binding measurements in a high-throughput setting, we identified the kinetic fingerprint of transient associations between WDR5 and 14-residue WDR5 interaction (Win) motif peptides of each SET1 protein (SET1Win). Our results reveal that the high-affinity WDR5-SET1Win interactions feature slow association kinetics. This finding is likely due to the requirement of SET1Win to insert into the narrow WDR5 cavity, also named the Win binding site. Furthermore, our explorations indicate fairly slow dissociation kinetics. This conclusion is in accordance with the primary role of WDR5 in maintaining the functional integrity of a large multisubunit complex, which regulates the histone methylation. Because the Win binding site is considered a key therapeutic target, the immediate outcomes of this study could form the basis for accelerated developments in medical biotechnology.

Indexed as

Protein Interaction Domains and MotifsAmino Acid MotifsBinding SitesHistone-Lysine N-MethyltransferaseHumansIntracellular Signaling Peptides and ProteinsKineticsPeptide FragmentsProtein BindingProtein ConformationHistone-Lysine N-MethyltransferaseIntracellular Signaling Peptides and ProteinsPeptide FragmentsSetd1A protein, humanWDR5 protein, humanbiolaye interferometryfluorescence polarizationmixed lineage leukemiaprotein–peptide interactionsSET1/MLL proteinssurface plasmon resonance

Identifiers

PMID34032265
PMCPMC8214142
OpenAlexW3165701279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.